null Option on Rhythm Pharmaceuticals
| RYTM Stock | USD 88.63 0.57 0.64% |
Rhythm Pharmaceuticals' latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.61 with a put-to-call open interest ratio of 19.04 over 40 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on October 17th 2025. The total put volume is at 22.0, with calls trading at the volume of 1.0. This yields a 22.0 put-to-call volume ratio.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Rhythm Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Rhythm Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Rhythm Pharmaceuticals' option, there is no secondary market available for investors to trade.
Rhythm Pharmaceuticals Maximum Pain Price Across 2025-10-17 Option Contracts
Max pain occurs when Rhythm Pharmaceuticals' market makers reach a net positive position across all Rhythm Pharmaceuticals' options at a strike price where option holders stand to lose the most money. By contrast, Rhythm Pharmaceuticals' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Rhythm Pharmaceuticals
Analyzing Rhythm Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Rhythm Pharmaceuticals regardless of its overall volatility. This is especially true when Rhythm Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Rhythm Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Rhythm Pharmaceuticals' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Rhythm Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Rhythm Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Rhythm Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Rhythm Stock moves the wrong way.
Rhythm Pharmaceuticals In The Money Call Balance
When Rhythm Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Rhythm Pharmaceuticals stock is said to be in the money. When it comes to buying Rhythm Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Rhythm Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Rhythm Current Options Market Mood
Rhythm Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Rhythm Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Rhythm Pharmaceuticals' options investors are not very successful. Rhythm Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Rhythm contract
Base on the Rule 16, the options market is currently suggesting that Rhythm Pharmaceuticals will have an average daily up or down price movement of about 0.0381% per day over the life of the 2025-10-17 option contract. With Rhythm Pharmaceuticals trading at USD 88.63, that is roughly USD 0.0338. If you think that the market is fully incorporating Rhythm Pharmaceuticals' daily price movement you should consider buying Rhythm Pharmaceuticals options at the current volatility level of 0.61%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Rhythm Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Rhythm calls. Remember, the seller must deliver Rhythm Pharmaceuticals stock to the call owner when a call is exercised.
Rhythm Pharmaceuticals Option Chain
When Rhythm Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Rhythm Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Rhythm Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Rhythm. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Rhythm. It also shows strike prices and maturity days for a Rhythm Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | RYTM251017C00140000 | 0 | 140.0 | 0.0 - 2.25 | 2.25 | |
Call | RYTM251017C00135000 | 0 | 135.0 | 0.0 - 2.3 | 2.3 | |
Call | RYTM251017C00130000 | 0 | 130.0 | 0.0 - 2.4 | 2.4 | |
Call | RYTM251017C00125000 | 0 | 125.0 | 0.0 - 2.5 | 2.5 | |
Call | RYTM251017C00120000 | 0 | 120.0 | 0.0 - 2.25 | 2.25 | |
Call | RYTM251017C00115000 | 0 | 115.0 | 0.1 - 2.3 | 0.1 | |
Call | RYTM251017C00110000 | 1 | 110.0 | 0.1 - 3.2 | 3.2 | Out |
Call | RYTM251017C00105000 | 1 | 105.0 | 0.7 - 4.4 | 4.25 | Out |
Call | RYTM251017C00100000 | 1 | 100.0 | 1.6 - 5.7 | 5.0 | Out |
Call | RYTM251017C00095000 | 36 | 95.0 | 3.4 - 5.9 | 5.9 | Out |
Call | RYTM251017C00090000 | 1 | 90.0 | 6.0 - 9.6 | 9.03 | Out |
Call | RYTM251017C00085000 | 3 | 85.0 | 8.6 - 12.0 | 10.5 | In |
Call | RYTM251017C00075000 | 3 | 75.0 | 15.7 - 19.1 | 17.9 | In |
Call | RYTM251017C00070000 | 12 | 70.0 | 19.1 - 23.0 | 8.5 | In |
Call | RYTM251017C00065000 | 17 | 65.0 | 23.4 - 26.7 | 27.0 | In |
Call | RYTM251017C00060000 | 3 | 60.0 | 27.9 - 32.0 | 27.9 | In |
Call | RYTM251017C00055000 | 1 | 55.0 | 32.6 - 36.7 | 32.6 | In |
Put | RYTM251017P00140000 | 0 | 140.0 | 49.3 - 53.5 | 49.3 | In |
Put | RYTM251017P00135000 | 0 | 135.0 | 44.3 - 48.5 | 44.3 | In |
Put | RYTM251017P00130000 | 0 | 130.0 | 39.3 - 43.5 | 39.3 | In |
Put | RYTM251017P00125000 | 0 | 125.0 | 34.3 - 38.5 | 34.3 | In |
Put | RYTM251017P00120000 | 2 | 120.0 | 29.4 - 32.5 | 28.65 | In |
Put | RYTM251017P00115000 | 0 | 115.0 | 24.7 - 28.8 | 24.7 | In |
Put | RYTM251017P00110000 | 1 | 110.0 | 20.4 - 24.1 | 23.8 | In |
Put | RYTM251017P00105000 | 0 | 105.0 | 16.5 - 20.1 | 16.5 | In |
Put | RYTM251017P00100000 | 3 | 100.0 | 12.4 - 16.2 | 16.0 | In |
Put | RYTM251017P00095000 | 0 | 95.0 | 9.2 - 13.0 | 9.2 | In |
Put | RYTM251017P00090000 | 6 | 90.0 | 6.4 - 9.9 | 8.7 | In |
Put | RYTM251017P00085000 | 9 | 85.0 | 4.0 - 8.0 | 6.28 | Out |
Put | RYTM251017P00080000 | 696 | 80.0 | 2.85 - 4.6 | 3.64 | Out |
Put | RYTM251017P00075000 | 693 | 75.0 | 1.05 - 4.8 | 2.75 | Out |
Put | RYTM251017P00070000 | 10 | 70.0 | 0.05 - 3.7 | 1.87 | Out |
Put | RYTM251017P00060000 | 20 | 60.0 | 0.0 - 2.4 | 5.7 | Out |
Put | RYTM251017P00055000 | 46 | 55.0 | 0.0 - 2.45 | 3.9 | Out |
Put | RYTM251017P00050000 | 2 | 50.0 | 0.0 - 2.3 | 2.6 | Out |
Put | RYTM251017P00045000 | 3 | 45.0 | 0.0 - 2.25 | 1.6 | Out |
Put | RYTM251017P00040000 | 3 | 40.0 | 0.0 - 2.2 | 1.0 | Out |
Put | RYTM251017P00035000 | 4 | 35.0 | 0.0 - 2.2 | 0.55 | Out |
Put | RYTM251017P00030000 | 3 | 30.0 | 0.0 - 2.15 | 2.15 | Out |
Put | RYTM251017P00025000 | 3 | 25.0 | 0.0 - 2.15 | 2.15 | Out |
Rhythm Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Rhythm Total Stockholder Equity
Total Stockholder Equity |
|
Rhythm Pharmaceuticals Corporate Management
| Jennifer Lee | Executive America | Profile | |
| Yann Mazabraud | Executive International | Profile | |
| Christopher German | Principal Controller | Profile | |
| Sarah Ryan | Vice Marketing | Profile | |
| Jim Flaherty | Senior Counsel | Profile | |
| Dana MD | Senior Development | Profile | |
| MD MBA | Senior Strategy | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rhythm Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.80) | Revenue Per Share | Quarterly Revenue Growth 0.259 | Return On Assets | Return On Equity |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.